Jeff E Borenstein

Summary

Affiliation: Cedars-Sinai Medical Center
Country: USA

Publications

  1. ncbi Physician-pharmacist comanagement of hypertension: a randomized, comparative trial
    Jeff E Borenstein
    Department of Medicine, Cedars Sinai Health System, Beverly Hills, California 90212, USA
    Pharmacotherapy 23:209-16. 2003
  2. ncbi Using the daily record of severity of problems as a screening instrument for premenstrual syndrome
    Jeff E Borenstein
    Departments of Medicine and Health Services Research, Cedars Sinai Health System and the UCLA School of Medicine, Los Angeles, California, USA
    Obstet Gynecol 109:1068-75. 2007
  3. ncbi Differences in symptom scores and health outcomes in premenstrual syndrome
    Jeff E Borenstein
    Department of Medicine, Cedars Sinai Medical Center and the UCLA School of Medicine, Los Angeles, California, USA
    J Womens Health (Larchmt) 16:1139-44. 2007
  4. ncbi Evaluating the criteria used for identification of PMS
    Bonnie B Dean
    Cerner Health Insights, Beverly Hills, California 90212, USA
    J Womens Health (Larchmt) 15:546-55. 2006
  5. ncbi Health and economic impact of the premenstrual syndrome
    Jeff E Borenstein
    Department of Medicine and Health Services Research, Cedars-Sinai Health System, University of California, Los Angeles School of Medicine, Los Angeles, USA
    J Reprod Med 48:515-24. 2003
  6. ncbi A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome
    Bonnie B Dean
    Cerner Health Insights, Beverly Hills, California, USA
    J Occup Environ Med 46:649-56. 2004
  7. ncbi Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?
    Bonnie B Dean
    Zynx Health, Inc, a Cerner Company, Beverly Hills, Calif 90212, USA
    Am Heart J 147:966-76. 2004

Detail Information

Publications7

  1. ncbi Physician-pharmacist comanagement of hypertension: a randomized, comparative trial
    Jeff E Borenstein
    Department of Medicine, Cedars Sinai Health System, Beverly Hills, California 90212, USA
    Pharmacotherapy 23:209-16. 2003
    ....
  2. ncbi Using the daily record of severity of problems as a screening instrument for premenstrual syndrome
    Jeff E Borenstein
    Departments of Medicine and Health Services Research, Cedars Sinai Health System and the UCLA School of Medicine, Los Angeles, California, USA
    Obstet Gynecol 109:1068-75. 2007
    ..To assess symptom ratings on the first day of menses to identify women at high risk of clinically significant premenstrual syndrome (PMS) who should undergo further evaluation...
  3. ncbi Differences in symptom scores and health outcomes in premenstrual syndrome
    Jeff E Borenstein
    Department of Medicine, Cedars Sinai Medical Center and the UCLA School of Medicine, Los Angeles, California, USA
    J Womens Health (Larchmt) 16:1139-44. 2007
    ....
  4. ncbi Evaluating the criteria used for identification of PMS
    Bonnie B Dean
    Cerner Health Insights, Beverly Hills, California 90212, USA
    J Womens Health (Larchmt) 15:546-55. 2006
    ....
  5. ncbi Health and economic impact of the premenstrual syndrome
    Jeff E Borenstein
    Department of Medicine and Health Services Research, Cedars-Sinai Health System, University of California, Los Angeles School of Medicine, Los Angeles, USA
    J Reprod Med 48:515-24. 2003
    ..006). CONCLUSION: Findings from this study suggest that premenstrual symptoms significantly affect health-related quality of life and may result in increased health care utilization and decreased occupational productivity...
  6. ncbi A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome
    Bonnie B Dean
    Cerner Health Insights, Beverly Hills, California, USA
    J Occup Environ Med 46:649-56. 2004
    ..Results indicate that PMS leads to substantial im in normal daily activities and occupational productivity and significantly increased work absenteeism...
  7. ncbi Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?
    Bonnie B Dean
    Zynx Health, Inc, a Cerner Company, Beverly Hills, Calif 90212, USA
    Am Heart J 147:966-76. 2004
    ..The narrow range of HDL-C level increases in the statin trials likely reduced our ability to detect a beneficial HDL-C effect, if present...